Treace Medical Concepts Inc (TMCI)
Healthcare
Medical Devices
4.30 $
-1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Treace Medical Concepts Inc (TMCI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.7% of the shares are freely tradable; institutional investors hold 57.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
57.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
25.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
73.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
65Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.81 | 6,364,000 | +0.0 | 03/31/2026 |
| Gagnon Securities LLC | 8.02 | 5,201,886 | +67.2 | 03/31/2026 |
| BlackRock Inc | 5.15 | 3,340,023 | -2.1 | 03/31/2026 |
| Bank of America Corp | 4.95 | 3,214,293 | +38.9 | 03/31/2026 |
| Vanguard Group Inc | 3.50 | 2,273,094 | -16.8 | 12/31/2025 |
| Atlantic Trust Group, LLC | 2.28 | 1,478,830 | -12.3 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.25 | 1,461,507 | +0.0 | 03/31/2026 |
| State Street Corp | 1.90 | 1,235,518 | +24.3 | 03/31/2026 |
| CIBC Bancorp USA Inc. | 1.88 | 1,218,353 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 1.78 | 1,151,732 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.